يعرض 321 - 340 نتائج من 21,342 نتيجة بحث عن '(( significant decrease decrease ) OR ( significant advances decrease ))*', وقت الاستعلام: 0.40s تنقيح النتائج
  1. 321

    NgR1 KO mice exhibited an increase in excitatory synapses and a decrease in inhibitory synapses, indicating an imbalance of synaptic transmission. حسب Jinwei Zhang (462455)

    منشور في 2025
    "…The inhibitory synaptic density of NgR1 mice showed a significant decrease when compared to WT mice (***P <  0.001). …"
  2. 322
  3. 323

    Y-27632 collaborated with BA to attenuate the increase in the integrity and decrease in the permeability of epithelial barrier injury induced by LPS in Caco2 monolayers. حسب Luqiong Liu (11537092)

    منشور في 2024
    "…(<b>C</b>) Y-27632 collaborated with BA to alleviate the decrease in FD-4 flux in LPS-induced Caco2 cells on day 22. …"
  4. 324
  5. 325
  6. 326
  7. 327

    Fig 3 - حسب Aihong Zheng (20571034)

    منشور في 2025
    الموضوعات:
  8. 328
  9. 329

    S1 Fig - حسب Aihong Zheng (20571034)

    منشور في 2025
    الموضوعات:
  10. 330
  11. 331
  12. 332

    Fig 4 - حسب Aihong Zheng (20571034)

    منشور في 2025
    الموضوعات:
  13. 333

    Patient selection flowchart. حسب Aihong Zheng (20571034)

    منشور في 2025
    الموضوعات:
  14. 334

    S2 Fig - حسب Aihong Zheng (20571034)

    منشور في 2025
    الموضوعات:
  15. 335

    Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i> حسب Razia Rashid Rahil (22772495)

    منشور في 2025
    "…(B, C) Summarized bar graph showed EVO significantly decreased calcium deposition and calcium content in CER treated P<sub>i</sub>-induced VSMCs. …"
  16. 336
  17. 337
  18. 338

    Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx حسب Tengxiang Zhao (20749475)

    منشور في 2025
    "…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…"
  19. 339

    Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx حسب Tengxiang Zhao (20749475)

    منشور في 2025
    "…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…"
  20. 340